PharmaVoice Blog

Premium industry intelligence for pharma media leaders

Sep 1, 2026

Why CMC readiness is becoming central to biopharma licensing deals

CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied

Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore

Express Pharma

Sep 1, 2026

Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore

In a regulatory filing, the company said the transaction was completed on August 31, 2026 The post Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore appeared first on Express Pharma.

Trump lines up MFN deals with nine mid-size pharmas on drug pricing push

Pharma Tech

Sep 1, 2026

Trump lines up MFN deals with nine mid-size pharmas on drug pricing push

These White House deals will require the nine midsize pharma companies to provide MFN prices to state Medicaid programmes nationally.

Eli Lilly continues near-monthly M&A presence with $2.9bn Merida deal

Pharma Tech

Sep 1, 2026

Eli Lilly continues near-monthly M&A presence with $2.9bn Merida deal

Merida's lead programme, MER511, is in Phase I development for Graves' disease and thyroid eye disease (TED).

PharmaEssentia’s Besremi receives FDA approval for ET

Pharma Tech

Sep 1, 2026

PharmaEssentia’s Besremi receives FDA approval for ET

The US FDA has approved PharmaEssentia’s Besremi (ropeginterferon alfa-2b-njft) to treat adults with essential thrombocythaemia (ET).

Kazia closes oversubscribed offering to fund paxalisib’s clinical development

Pharma Tech

Sep 1, 2026

Kazia closes oversubscribed offering to fund paxalisib’s clinical development

Kazia Therapeutics has closed an oversubscribed public offering that could provide the company with up to $120m in gross proceeds if all milestone-linked warrants are exercised, aimed primarily at funding clinical development of paxalisib.

Brand stories and partner placements

Jeplus.in

Purchase All Medicines.Get 10% Offer